Turning Point Therapeutics Announces Updated Interim Clinical Data of Repotrectinib in Advanced ROS1+ Non-Small Cell Lung Cancer

    NEXT STORY
    Kite and Humanigen Announce Clinical Collaboration to Evaluate Investigational Combination of Yescarta® (axicabtagene ciloleucel) With lenzilumab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    PREV STORY
    Aptose to Present at the Jefferies 2019 Healthcare Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    THE ELSAH PROJECT PUSHES THE LIMITS OF WEARABLES

    author_avatar
    NASDAQ Market News

    Cellular Biomedicine Group to Present at the Cantor Fitzgerald Global Healthcare Conference

    SHANGHAI, China and CUPERTINO, Calif., Sept. 14, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group ...

    author_avatar
    NASDAQ Market News

    Infection Control & Biosafety Products Market, 2018-2023 – In 2018, Combined Global Sales of Injection Devices Totaled $2.7Bn, with Safety Needles & Syringes Accounting for Nearly 90% of Sales

    author_avatar
    NASDAQ Market News